Skip to main content
Hit enter to search or ESC to close
Close Search
Mirus Capital Advisors
search
Menu
  • Industry Focus
    • Technology
    • Industrial
    • Business Services
    • Healthcare & Life Sciences
    • Consumer
  • Services
    • M&A Advisory
    • Capital Advisory
    • Fairness Opinions & Valuations
  • Clients
  • Team
  • About
    • Message from Our Leadership
    • Transactions
    • Global Reach
    • Culture
    • Careers
    • News & Insights
  • Contact
  • search
  • Industry Focus
    • Technology
    • Industrial
    • Business Services
    • Healthcare & Life Sciences
    • Consumer
  • Services
    • M&A Advisory
    • Capital Advisory
    • Fairness Opinions & Valuations
  • Clients
  • Team
  • About
    • Message from Our Leadership
    • Transactions
    • Global Reach
    • Culture
    • Careers
    • News & Insights
  • Contact

News & Insights

Keensight Capital Acquires Majority Stake in Isto Biologics | A portfolio company of Thompston Street Capital Partners | Mirus Capital Advisors
Mirus Capital Advisors Serves as Financial Advisor to Keensight Capital on its Acquisition of a Majority Stake in Isto Biologics

Mirus Capital Advisors Serves as Financial Advisor to Keensight Capital on its Acquisition of a Majority Stake in Isto Biologics

Mirus Capital Advisors, Inc., a leading independent middle-market investment banking firm, is pleased to announce…
pagano
paganoSeptember 18, 2025
TheraCell acquired by Isto Biologics a portfolio company of Thompson Street Capital Partners | Mirus Capital Advisors | Healthcare Investment Bankers
Mirus Advises TheraCell on its Sale to Isto Biologics

Mirus Advises TheraCell on its Sale to Isto Biologics

Mirus Capital Advisors is pleased to announce that it served as the exclusive financial advisor…
pagano
paganoApril 7, 2022
AdvanSource Biomaterials sold its assets to mcpp, a company of Mitsubishi Chemical | Mirus Capital Advisors | Top Investment Bank
Mirus Client AdvanSource Biomaterials Corporation Completes the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America

Mirus Client AdvanSource Biomaterials Corporation Completes the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America

Burlington, MA – Mirus Capital Advisors announced today that it acted as the exclusive financial…
pagano
paganoFebruary 10, 2020
Mobilize Rescue Systems acquired by ZOLL, a division of AsahiKASEI | Mirus Capital Advisors | Premier Middle Market Investment Bank
Mirus advises Mobilize RRS in its sale to Zoll

Mirus advises Mobilize RRS in its sale to Zoll

Mirus Capital Advisors acted as the exclusive financial advisor to Mobilize RRS (Mobilize) in its…
pagano
paganoAugust 5, 2019
Bio2 Technologies received an investment from DSM | Mirus Capital Advisors | Healthcare & Life Sciences Investment Bankers
BIO2 TECHNOLOGIES, INC. CLOSES SERIES C EQUITY FINANCING

BIO2 TECHNOLOGIES, INC. CLOSES SERIES C EQUITY FINANCING

Mirus Capital Advisors announced today that it acted as the exclusive financial advisor to Bio2…
pagano
paganoJanuary 7, 2019
Belmony Instrument Corporation has been recapitalized by Audax Group | Mirus Capital Advisors | Premier Middle Market Investment Bank
Audax Recapitalizes Belmont Instrument Corporation

Audax Recapitalizes Belmont Instrument Corporation

Mirus Capital Advisors announced today that it acted as the exclusive financial advisor to Belmont…
pagano
paganoJanuary 5, 2018
VuCOMP sold its M-Vu Breast Density Software to iCad | Mirus Capital Advisors | Healthcare & Life Sciences Investment Bankers
VuCOMP Announces Sale of M-Vu to iCAD, Inc.

VuCOMP Announces Sale of M-Vu to iCAD, Inc.

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer,…
pagano
paganoJuly 20, 2015
Apple Medical Corporation acquired by Cooper Surgical | Mirus Capital Advisors | Healthcare Investment Bankers
Apple Medical Corporation has been acquired by CooperSurgical, Inc.

Apple Medical Corporation has been acquired by CooperSurgical, Inc.

Mirus Capital Advisors, a middle-market investment bank specializing in mergers and acquisitions, announced today that…
pagano
paganoApril 15, 2011
Mirus Capital Advisors | White Logo | Middle-Market Investment Bank

Mirus Capital Advisors is the parent company of Mirus Securities Inc.

Mirus Securities Inc. is a member of FINRA and SIPC. Check the background of this firm in FINRA’s BrokerCheck.

Contact

200 Summit Drive
4th Floor South
Burlington, MA 01803

Phone Icon | Mirus Capital Advisors
781.418.5900
Email Icon | Mirus Capital Advisors
781.418.5999
Envelope Icon | Mirus Capital Advisors
info@merger.com
Recent News

January 2026 Middle Market Monitor

Patti | Business Services, Consumer, Featured Report, Healthcare & Life Sciences, Industrial, Technology | No Comments
Each month at Mirus, we dig into the data that's shaping the middle market landscape. Our latest Middle Market Monitor provides a snapshot of key economic metrics and investor activities…
Mirus Capital Advisors | Logo | News & Insights Featured Image

2025 Year in Review

Patti | Business Services, Consumer, Healthcare & Life Sciences, Industrial, News & Insights, Technology | No Comments
As we begin 2026, we are grateful for the clients who trust us with their most important transactions, for the professional advisors who work alongside us, and for the talented…
Downloads

About Mirus

Stay In Touch

Subscribe to our News & Insights

©2026 Mirus Capital Advisors. All Rights Reserved. Privacy Policy. Business Continuity Plan. Cookie Policy.

Manage Consent

Manage Consent | By using this website, you agree to our use of cookies to enable essential site functionality and perform analytics. You may opt-out by clicking on Cookie Policy

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}